470 related articles for article (PubMed ID: 15332267)
1. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
Inoue N; Spira T; Lam L; Corchero JL; Luo W
J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
[TBL] [Abstract][Full Text] [Related]
2. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
3. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
[TBL] [Abstract][Full Text] [Related]
4. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
5. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
[TBL] [Abstract][Full Text] [Related]
6. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs.
Chandran B; Smith MS; Koelle DM; Corey L; Horvat R; Goldstein E
Virology; 1998 Mar; 243(1):208-17. PubMed ID: 9527930
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.
Ariyoshi K; Schim van der Loeff M; Cook P; Whitby D; Corrah T; Jaffar S; Cham F; Sabally S; O'Donovan D; Weiss RA; Schulz TF; Whittle H
J Hum Virol; 1998; 1(3):193-9. PubMed ID: 10195242
[TBL] [Abstract][Full Text] [Related]
9. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
Caterino-de-Araujo A; Magri MC; Manuel RC
J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
[TBL] [Abstract][Full Text] [Related]
10. Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma.
Guihot A; Dupin N; Marcelin AG; Gorin I; Bedin AS; Bossi P; Galicier L; Oksenhendler E; Autran B; Carcelain G
J Infect Dis; 2006 Oct; 194(8):1078-88. PubMed ID: 16991082
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C
AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
[TBL] [Abstract][Full Text] [Related]
13. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma.
Gao SJ; Kingsley L; Hoover DR; Spira TJ; Rinaldo CR; Saah A; Phair J; Detels R; Parry P; Chang Y; Moore PS
N Engl J Med; 1996 Jul; 335(4):233-41. PubMed ID: 8657239
[TBL] [Abstract][Full Text] [Related]
14. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma.
Laney AS; Cannon MJ; Jaffe HW; Offermann MK; Ou CY; Radford KW; Patel MM; Spira TJ; Gunthel CJ; Pellett PE; Dollard SC
AIDS; 2007 Jul; 21(12):1541-5. PubMed ID: 17630548
[TBL] [Abstract][Full Text] [Related]
15. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma.
Jacobson LP; Jenkins FJ; Springer G; Muñoz A; Shah KV; Phair J; Zhang Z; Armenian H
J Infect Dis; 2000 Jun; 181(6):1940-9. PubMed ID: 10837173
[TBL] [Abstract][Full Text] [Related]
16. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
17. Sexual transmission and the natural history of human herpesvirus 8 infection.
Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
[TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus 8 cellular immune responses in homosexual men.
Strickler HD; Goedert JJ; Bethke FR; Trubey CM; O'Brien TR; Palefsky J; Whitman JE; Ablashi D; Zeichner S; Shearer GM
J Infect Dis; 1999 Nov; 180(5):1682-5. PubMed ID: 10515832
[TBL] [Abstract][Full Text] [Related]
19. Human herpesvirus 8 and Kaposi's sarcoma in persons infected with human immunodeficiency virus.
Gnann JW; Pellett PE; Jaffe HW
Clin Infect Dis; 2000 Apr; 30 Suppl 1():S72-6. PubMed ID: 10770915
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A; Albrecht D; Lorenzen T; Meyer T; Arndt R; Stoehr A
Eur J Med Res; 2002 Jan; 7(1):19-24. PubMed ID: 11827836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]